Opevesostat
Opevesostat (MK-5684; ODM-208) is an orally active and selective CYP11A1 inhibitor. Opevesostat has the potential for the research of metastatic castration-resistant prostate cancer (mCRPC) [1].
Product Specifications
CAS Number
2231294-96-3
Product Name Alternative
MK-5684; ODM-208
UNSPSC
12352005
Target
Cytochrome P450
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/opevesostat.html
Purity
99.79
Solubility
DMSO : 50 mg/mL (ultrasonic)
Smiles
O=C1C=C(CN2CC3=C(C2)C=CC=C3)OC=C1OCC4CCN(S(=O)(C)=O)CC4
Molecular Formula
C21H26N2O5S
Molecular Weight
418.51
References & Citations
[1]Fizazi, K. et al. 1605P Opevesostat (MK-5684/ODM-208), an oral CYP11A1 inhibitor, in metastatic castration-resistant prostate cancer (mCRPC) : Updated CYPIDES phase II results. Annals of Oncology, Volume 35, S968.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 3
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
![HDAC8 Mouse Monoclonal Antibody [Clone ID: OTI1B2]](https://cdn.genprice.uk/products/937/68dd18ba061270361e90867e/imageurl/cf809667.webp)
